Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study

Frederik B Thomsen1, Yasin Folkvaljon2, Hans Garmo3

  • 1Department of Urology, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark.

Insights

Men with prostate cancer show an increased risk for melanoma, particularly early-stage disease. Factors like low-risk prostate cancer, high socioeconomic status, and southern Sweden residency are associated with this elevated melanoma risk.

Area of Science:

  • Oncology
  • Dermatology
  • Epidemiology

Background:

  • An elevated risk of malignant melanoma has been noted in men diagnosed with prostate cancer.
  • Shared risk factors or confounding variables may underlie this observed association.

Purpose of the Study:

  • To investigate the risk of melanoma in men with prostate cancer.
  • To identify potential shared or confounding risk factors, including tumor characteristics and socioeconomic status.

Main Methods:

  • Analysis of a cohort of men with prostate cancer and a comparison cohort without prostate cancer using The Prostate Cancer data Base Sweden.
  • Utilized nationwide registers for data on prostate cancer risk, melanoma stage, basal cell carcinoma, residency, and socioeconomic status.
  • Employed multivariable Cox regression models to assess risk associations.

Main Results:

  • Men with prostate cancer exhibited a significantly increased risk of melanoma (HR 1.18).
  • Increased melanoma risk was also linked to marriage, high education, high income, and southern Sweden residency.
  • Strongest associations for early-stage melanoma (Stage 0) were found in men with low-risk prostate cancer, high education, and high income.
  • No association was observed between these factors and late-stage melanoma.
  • Men with prostate cancer also had an increased risk of basal cell carcinoma (HR 1.18).

Conclusions:

  • Men with low-risk prostate cancer, high education, high income, and residing in southern Sweden face an increased risk of early-stage melanoma.
  • These findings highlight specific demographic and clinical factors associated with heightened melanoma risk in prostate cancer patients.